Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties

The oncogene HER2 is an important molecular target in oncology because it is associated with aggressive disease and the worst prognosis. The development of non-invasive imaging techniques and target therapies using monoclonal antibodies is a rapidly developing field. Thus, this work proposes the stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Ana Cláudia Camargo, dos Santos, Sofia Nascimento, Fuscaldi, Leonardo Lima, Balieiro, Luiza Mascarenhas, Bellini, Maria Helena, Guimarães, Maria Inês Calil Cury, de Araújo, Elaine Bortoleti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309196/
https://www.ncbi.nlm.nih.gov/pubmed/34198999
http://dx.doi.org/10.3390/pharmaceutics13070971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309196/
https://www.ncbi.nlm.nih.gov/pubmed/34198999
http://dx.doi.org/10.3390/pharmaceutics13070971

Ejemplares similares